Compliance with RSV prophylaxis: Global physicians’ perspectives
Kari S Anderson, Victoria M Mullally, Linda M Fredrick, Andrew L CampbellAbbott Laboratories, Abbott Park, IL, USAAbstract: Respiratory syncytial virus (RSV) is a significant cause of morbidity in high-risk infants.
Kari S Anderson +3 more
core
Adjuvanted RSVPreF3 vaccine impact over three respiratory syncytial virus seasons in older adults with comorbidities. [PDF]
Papi A +15 more
europepmc +1 more source
Epidemiology of human RSV in Taiwan, 2018-2024. [PDF]
Yang SL +6 more
europepmc +1 more source
Resveratrol mitigates hypoxia-induced mitochondrial oxidative damage and apoptosis <i>via</i> inhibition of TRPA1 channel in retinal pigment epithelial cells. [PDF]
Argun M, Nazıroğlu M.
europepmc +1 more source
Clinical Outcomes of Respiratory Syncytial Virus Versus Influenza Pneumonia in Critically Ill Adults. [PDF]
Yayan J.
europepmc +1 more source
Respiratory Syncytial Virus Vaccination Strongly Induces RSVpreF-specific IgG and Neutralizing Activity in Immunocompromised Individuals. [PDF]
Bronder S +10 more
europepmc +1 more source
Healthcare resource use and costs following RSV-related hospitalizations among US adults aged 50 years and older. [PDF]
Singer D +5 more
europepmc +1 more source
Burden of respiratory syncytial virus (RSV) hospitalizations among adults aged 60 years or more in Brazil: A retrospective surveillance database analysis (2013-2024). [PDF]
de Veras BMG +8 more
europepmc +1 more source
Long-term stability of the GMP-compliant recombinant BCG vaccine against human RSV under quality control analyses. [PDF]
Troncoso-Bravo T +14 more
europepmc +1 more source

